Chiron to distribute Cardiovascular tests:
This article was originally published in Clinica
Executive Summary
Chiron Diagnostics will take on worldwide distribution of Cardiovascular Diagnostics' near-patient coagulation tests. In the US, Chiron will start distribution in January 1999, as Cardiovascular's current marketing agreements, with Dade Behring and Avecor Cardiovascular, expire. Chiron will launch the tests separately, as well as incorporating them onto its Rapidpoint 400 critical care system, set for a launch this year. According to Chiron, the coagulation products are part of its strategy to "redefine our critical care product portfolio". Chiron will also invest $6 million in Cardiovascular stock.